PAS-G supports platelet reconstitution after cryopreservation in the absence of plasma

Transfusion

Volumn 53, Issue 10, 2013, Pages 2268-2277

  Johnson, Lacey ^a   Reid, Samantha ^a   Tan, Shereen ^a   Vidovic, Diana ^a   Marks, Denese C ^a  

^a Research and Development   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE;

ARTICLE; BLOOD COMPONENT; BLOOD PH; BLOOD STORAGE; CENTRIFUGATION; CRYOPRESERVATION; FREEZING; HUMAN; HUMAN CELL; IN VITRO STUDY; PLASMA; THAWING; THROMBOCYTE; THROMBOCYTE AGGREGATION;

BLOOD PLATELETS; BLOOD PRESERVATION; CRYOPRESERVATION; DIMETHYL SULFOXIDE; GLUCOSE; HUMANS;

EID: 84885851254     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12084     Document Type: Article

References (41)

1. Greening DW, Glenister KM, Sparrow RL, Simpson RJ,. International blood collection and storage: clinical use of blood products. J Proteomics 2010; 73: 386-395.
2. Khuri S, Healey N, MacGregor H, Barnard M, Szymanski I, Birjiniuk V, Michelson A, Gagnon D, Valeri C,. Comparison of the effects of transfusions of cryopreserved and liquid-preserved platelets on hemostasis and blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999; 117: 172-183.
3. Valeri CR, Rithy S, Joseph PL, Gina R,. Effect of WBC reduction and storage temperature on PLTs frozen with 6 percent DMSO for as long as 3 years. Transfusion 2003; 43: 1162-1167. (Pubitemid 37022379)
4. Hess JR, Holcomb JB,. Transfusion practice in military trauma. Transfus Med 2008; 18: 143-150. (Pubitemid 351847330)
5. Landi EP, Roveri EG, Ozelo MC, Annichino-Bizzacchi JM, Origa AF, de, Carvalho Reis AR, de, Souza CA, Marques JF,. Effects of high platelet concentration in collecting and freezing dry platelets concentrates. Transfus Apher Sci 2004; 30: 205-212. (Pubitemid 38698335)
6. Angelini A, Dragani A, Berardi A, Iacone A, Fioritoni G, Torlontano G,. Evaluation of four different methods for platelet freezing: in vitro and in vivo studies. Vox Sang 1992; 62: 146-151.
7. Hornsey VS, McMillan L, Morrison A, Drummond O, MacGregor IR, Prowse CV,. Freezing of buffy coat-derived, leukoreduced platelet concentrates in 6 percent dimethyl sulfoxide. Transfusion 2008; 48: 2508-2514.
8. Lelkens CC, Koning JG, de, Kort B, Floot IB, Noorman F,. Experiences with frozen blood products in the Netherlands military. Transfus Apher Sci 2006; 34: 289-298. (Pubitemid 44247907)
9. Dumont LJ, Cancelas JA, Dumont DF, Siegel AH, Szczepiorkowski ZM, Rugg N, Pratt PG, Worsham DN, Hartman EL, Dunn SK, O'Leary M, Ransom JH, Michael RA, Macdonald VW,. A randomized controlled trial evaluating recovery and survival of 6% dimethyl sulfoxide-frozen autologous platelets in healthy volunteers. Transfusion 2013; 53: 128-137.
10. Andreu G, Vasse J, Sandid I, Tardivel R, Semana G,. Use of random versus apheresis platelet concentrates. Transfus Clin Biol 2007; 14: 514-521.
11. Ringwald J, Zimmermann R, Eckstein R,. The new generation of platelet additive solution for storage at 22°C: development and current experience. Transfus Med Rev 2006; 20: 158-164.
12. van der Meer PF,. Platelet additive solutions: a future perspective. Transfus Clin Biol 2007; 14: 522-525.
13. + platelet additive solution. Vox Sang 2006; 91: 41-46. (Pubitemid 43822303)
14. Saunders C, Rowe G, Wilkins K, Holme S, Collins P,. In vitro storage characteristics of platelet concentrates suspended in 70% SSP+ additive solution versus plasma over a 14-day storage period. Vox Sang 2011; 101: 112-121.
15. Johnson LN, Winter KM, Reid S, Hartkopf-Theis T, Marks DC,. Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution. Cryobiology 2011; 62: 100-106.
16. Gyongyossy-Issa MI, Zhang JG, Culibrk B, Hunter F, Levin E, Scammell K, Weiss S, Holmes DL, Holme S,. Novel system for storage of buffy-coat-derived platelet concentrates in a glucose-based platelet additive solution: parameters and metabolism during storage and comparison to plasma. Vox Sang 2009; 97: 102-109.
17. Alhumaidan H, Cheves T, Holme S, Sweeney JD,. Manufacture of pooled platelets in additive solution and storage in an ELX container after an overnight warm temperature hold of platelet-rich plasma. Am J Clin Pathol 2011; 136: 638-645.
18. Radwanski K, Wagner SJ, Skripchenko A, Min K,. In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5. Transfusion 2012; 52: 188-194.
19. Johnson L, Winter KM, Reid S, Hartkopf-Theis T, Marschner S, Goodrich RP, Marks DC,. The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover. Vox Sang 2011; 101: 208-214.
20. Bertolini F, Murphy S,; Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood T. A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Transfusion 1996; 36: 128-132. (Pubitemid 26070875)
21. Johnson L, Winter KM, Hartkopf-Theis T, Reid S, Kwok M, Marks DC,. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution. Transfusion 2012; 52: 503-509.
22. Ohto H, Ezuki S, Kanno T, Nollet KE,. Extending platelet storage: safety and quality considerations. ISBT Sci Ser 2009; 4: 266-270.
23. Council of Europe. Guide to the preparation, use and quality assurance of blood components. 14th ed. Strasbourg, France: Council of Europe Publishing; 2008.
24. Gulliksson H,. Defining the optimal storage conditions for the long-term storage of platelets. Transfus Med Rev 2003; 17: 209-215. (Pubitemid 36900328)
25. Valeri CR, Ragno G,. The effect of storage of fresh-frozen plasma at -80°C for as long as 14 years on plasma clotting proteins. Transfusion 2005; 45: 1829-1830. (Pubitemid 43923916)
26. Neuhaus SJ, Wishaw K, Lelkens C,. Australian experience with frozen blood products on military operations. Med J Aust 2010; 192: 203-205.
27. Dijkstra-Tiekstra MJ, de Korte D, Pietersz RN, Reesink HW, van der, Meer PF, Verhoeven AJ,. Comparison of various dimethylsulphoxide-containing solutions for cryopreservation of leucoreduced platelet concentrates. Vox Sang 2003; 85: 276-282. (Pubitemid 37522601)
28. National Blood Service. Guidelines for the blood transfusion services in the UK. 7th ed. London: The Stationery Office; 2005.
29. Zhang JG, Carter CJ, Culibrk B, Devine DV, Levin E, Scammell K, Weiss S, Gyongyossy-Issa MI,. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma. Transfusion 2008; 48: 847-856. (Pubitemid 351614913)
30. Goodrich RP, Li J, Pieters H, Crookes R, Roodt J, Heyns Adu P,. Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sang 2006; 90: 279-285.
31. Gyongyossy-Issa MI,. Glucose in platelet additive solutions: to add or not to add? Transfus Apher Sci 2011; 44: 283-295.
32. Amorini AM, Tuttobene M, Tomasello FM, Biazzo F, Gullotta S, Pinto VD, Lazzarino G, Tavazzi B,. Glucose ameliorates the metabolic profile and mitochondrial function of platelet concentrates during storage in autologous plasma. Blood Transfus 2012; 13: 1-10.
33. Dekkers DW, De Cuyper IM, Van Der Meer PF, Verhoeven AJ, De Korte D,. Influence of pH on stored human platelets. Transfusion 2007; 47: 1889-1895. (Pubitemid 47438557)
34. Barnard MR, MacGregor H, Ragno G, Pivacek LE, Khuri SF, Michelson AD, Valeri CR,. Fresh, liquid-preserved, and cryopreserved platelets: adhesive surface receptors and membrane procoagulant activity. Transfusion 1999; 39: 880-888. (Pubitemid 30452054)
35. Rumjantseva V, Hoffmeister KM,. Novel and unexpected clearance mechanisms for cold platelets. Transfus Apher Sci 2010; 42: 63-70.
36. Valeri CR, Ragno G,. Cryopreservation of human blood products. Transfus Apher Sci 2006; 34: 271-287. (Pubitemid 44247906)
37. Pedrazzoli P, Noris P, Perotti C, Schiavo R, Ponchio L, Belletti S, Prada GA, Balduini CL, Salvaneschi L, Robustelli Della Cuna G, Siena S,. Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot study. Br J Haematol 2000; 108: 653-659. (Pubitemid 30196264)
38. Vadhan-Raj S, Kavanagh JJ, Freedman RS, Folloder J, Currie LM, Bueso-Ramos C, Verschraegen CF, Narvios AB, Connor J, Hoots WK, Broemeling LD, Lichtiger B,. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study. Lancet 2002; 359: 2145-2152. (Pubitemid 34694021)
39. Valeri CR, Gina R, Shukri K,. Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at -80°C without postthaw processing. Transfusion 2005; 45: 1890-1898. (Pubitemid 43971415)
40. Brown JB, Cohen MJ, Minei JP, Maier RV, West MA, Billiar TR, Peitzman AB, Moore EE, Cushieri J, Sperry JL,. Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion. Journal of Trauma and Acute Care. Surgery 2012; 73: 358-364.
41. Schiffer CA, Aisner J, Wiernik PH,. Clinical experience with transfusion of cryopreserved platelets. Br J Haematol 1976; 34: 377-385.